{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:42:30Z","timestamp":1793727750462,"version":"4.6.1"},"reference-count":81,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,6]]},"abstract":"<jats:p>\n                    G protein-coupled receptor 37 (\n                    <jats:italic toggle=\"yes\">GPR37<\/jats:italic>\n                    ) and G protein-coupled receptor 37 like 1 (\n                    <jats:italic toggle=\"yes\">GPR37L1<\/jats:italic>\n                    ) are implicated in tumorigenesis; however, their prognostic significance and roles in chemotherapy and immunotherapy responses across diverse cancers is incompletely defined. Utilizing transcriptomic, genomic, pharmacogenomic, and clinical data, we mapped the molecular landscapes of\n                    <jats:italic toggle=\"yes\">GPR37<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">GPR37L1<\/jats:italic>\n                    and assessed their potential clinical value in retrospective real-world cohorts. Our analysis revealed high genetic alteration rates for\n                    <jats:italic toggle=\"yes\">GPR37<\/jats:italic>\n                    (10.2%) and\n                    <jats:italic toggle=\"yes\">GPR37L1<\/jats:italic>\n                    (10.7%). Aberrant expression of\n                    <jats:italic toggle=\"yes\">GPR37<\/jats:italic>\n                    served as a predictive biomarker for survival outcomes in breast invasive carcinoma, lower grade gliomas, and lung adenocarcinoma, a pattern similarly observed for\n                    <jats:italic toggle=\"yes\">GPR37L1<\/jats:italic>\n                    . Intriguingly, the 2 receptors exhibited divergent prognostic effects in adrenocortical carcinoma, cervical squamous cell carcinoma and endocervical adenocarcinoma, lung squamous cell carcinoma, stomach adenocarcinoma, uterine corpus endometrial carcinoma, and uveal melanoma. Evaluation of chemotherapy response identified significant correlations between the expression levels of both\n                    <jats:italic toggle=\"yes\">GPR37<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">GPR37L1<\/jats:italic>\n                    and sensitivity to 21 common chemotherapeutic agents. For example, in lung adenocarcinoma, the elevated expression of either receptor was significantly associated with reduced sensitivity to cisplatin and gemcitabine. Analysis of 2 immunotherapy-treated melanoma cohorts demonstrated that high\n                    <jats:italic toggle=\"yes\">GPR37<\/jats:italic>\n                    or\n                    <jats:italic toggle=\"yes\">GPR37L1<\/jats:italic>\n                    expression correlated with inferior overall survival, a finding corroborated by immune infiltration and chemokine profiles. Our in vitro experiments demonstrated that the proposed ligand TX14A was unable to activate\n                    <jats:italic toggle=\"yes\">GPR37<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">GPR37L1<\/jats:italic>\n                    through the cyclic adenosine monophosphate or extracellular signal-regulated kinase\/mitogen-activated protein kinase pathways. Notably, this is the first systematic pan-cancer profiling of both\n                    <jats:italic toggle=\"yes\">GPR37<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">GPR37L1<\/jats:italic>\n                    that integrates analyses of chemotherapy sensitivity, immunotherapy response, and immune landscapes.\n                    <jats:italic toggle=\"yes\">GPR37<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">GPR37L1<\/jats:italic>\n                    may represent candidate biomarkers for prognostic stratification and for predicting chemotherapy and immunotherapy response.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047813","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:02:55Z","timestamp":1773043375000},"page":"e47813","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic, chemotherapy and immunotherapy roles of GPR37\/GPR37L1 in pan-cancer"],"prefix":"10.1097","volume":"105","author":[{"given":"Guoqiang","family":"Zhu","sequence":"first","affiliation":[{"name":"Key Laboratory of Bio-Resources and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiliang","family":"He","sequence":"additional","affiliation":[{"name":"Key Laboratory of Bio-Resources and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningkun","family":"Shi","sequence":"additional","affiliation":[{"name":"Key Laboratory of Bio-Resources and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyao","family":"Cai","sequence":"additional","affiliation":[{"name":"Sheng Yushou Center of Cell Biology and Immunology, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Bio-Resources and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna Chau Yi","family":"Wang","sequence":"additional","affiliation":[{"name":"University of New South Wales, School of Biological, Earth and Environmental Sciences, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Bio-Resources and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery, Sichuan Academy of Medical Sciences and Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1347-0549","authenticated-orcid":false,"given":"Yajun","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Bio-Resources and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261009","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.prp.2014.07.011","article-title":"A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival.","volume":"210","author":"Liu","year":"2014","journal-title":"Pathol Res Pract"},{"key":"R2-20261009","doi-asserted-by":"crossref","first-page":"106389","DOI":"10.1016\/j.phrs.2022.106389","article-title":"GPR37 promotes cancer growth by binding to CDK6 and represents a new theranostic target in lung adenocarcinoma.","volume":"183","author":"Xie","year":"2022","journal-title":"Pharmacol Res"},{"key":"R3-20261009","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1515\/med-2021-0011","article-title":"GPR37 promotes the malignancy of lung adenocarcinoma via TGF-beta\/Smad pathway.","volume":"16","author":"Wang","year":"2021","journal-title":"Open Med"},{"key":"R4-20261009","doi-asserted-by":"crossref","first-page":"101819","DOI":"10.1016\/j.tranon.2023.101819","article-title":"GPR37-centered ceRNA network contributes to metastatic potential in lung adenocarcinoma: evidence from high-throughput sequencing.","volume":"39","author":"Chen","year":"2024","journal-title":"Transl Oncol"},{"key":"R5-20261009","first-page":"341","article-title":"Up-regulation of GPR37 promotes the proliferation of human glioma U251 cells.","volume":"34","author":"Zhang","year":"2018","journal-title":"Chin J Cell Mol Immunol"},{"key":"R6-20261009","doi-asserted-by":"crossref","first-page":"10146","DOI":"10.18632\/aging.205063","article-title":"GPR37 expression as a prognostic marker in gliomas: a bioinformatics-based analysis.","volume":"15","author":"Liang","year":"2023","journal-title":"Aging (Milano)"},{"key":"R7-20261009","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1038\/s41388-023-02841-0","article-title":"GPR37 promotes colorectal cancer liver metastases by enhancing the glycolysis and histone lactylation via Hippo pathway.","volume":"42","author":"Zhou","year":"2023","journal-title":"Oncogene"},{"key":"R8-20261009","doi-asserted-by":"crossref","first-page":"27874","DOI":"10.18632\/oncotarget.8442","article-title":"REG4 promotes peritoneal metastasis of gastric cancer through GPR37.","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"R9-20261009","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.leukres.2013.11.007","article-title":"The role of the orphan G protein-coupled receptor 37 (GPR37) in multiple myeloma cells.","volume":"38","author":"Huang","year":"2014","journal-title":"Leuk Res"},{"key":"R10-20261009","doi-asserted-by":"crossref","first-page":"104021","DOI":"10.1016\/j.psj.2024.104021","article-title":"Comparative transcriptomic study on the ovarian cancer between chicken and human.","volume":"103","author":"Zhu","year":"2024","journal-title":"Poult Sci"},{"key":"R11-20261009","doi-asserted-by":"crossref","first-page":"19777","DOI":"10.1002\/cam4.6543","article-title":"Activation of PI3K\/Akt pathway by G protein\u2010coupled receptor 37 promotes resistance to cisplatin\u2010induced apoptosis in non\u2010small cell lung cancer.","volume":"12","author":"Liu","year":"2023","journal-title":"Cancer Med"},{"key":"R12-20261009","doi-asserted-by":"crossref","first-page":"107746","DOI":"10.1016\/j.phrs.2025.107746","article-title":"Neuroprotectin D1 and GPR37 protect against chemotherapy-induced peripheral neuropathy and the transition from acute to chronic pain.","volume":"216","author":"Xu","year":"2025","journal-title":"Pharmacol Res"},{"key":"R13-20261009","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/s41467-021-21940-8","article-title":"Activation of GPR37 in macrophages confers protection against infection-induced sepsis and pain-like behaviour in mice.","volume":"12","author":"Bang","year":"2021","journal-title":"Nat Commun"},{"key":"R14-20261009","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1172\/JCI99888","article-title":"GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain.","volume":"128","author":"Bang","year":"2018","journal-title":"J Clin Invest"},{"key":"R15-20261009","doi-asserted-by":"crossref","first-page":"112808","DOI":"10.1016\/j.celrep.2023.112808","article-title":"Efferocytes release extracellular vesicles to resolve inflammation and tissue injury via prosaposin-GPR37 signaling.","volume":"42","author":"Bhattacharya","year":"2023","journal-title":"Cell Rep"},{"key":"R16-20261009","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.3390\/ijms23074028","article-title":"Emerging roles for the orphan GPCRs, GPR37 and GPR37 L1, in stroke pathophysiology.","volume":"23","author":"Mouhi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R17-20261009","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1021\/acschemneuro.3c00479","article-title":"Orphan G protein-coupled receptor GPR37 as an emerging therapeutic target.","volume":"14","author":"Bolinger","year":"2023","journal-title":"ACS Chem Neurosci"},{"key":"R18-20261009","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fphar.2015.00275","article-title":"Drug discovery opportunities at the endothelin B receptor-related orphan G protein-coupled receptors, GPR37 and GPR37L1.","volume":"6","author":"Smith","year":"2015","journal-title":"Front Pharmacol"},{"key":"R19-20261009","doi-asserted-by":"crossref","first-page":"9529","DOI":"10.1073\/pnas.1219004110","article-title":"GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin.","volume":"110","author":"Meyer","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"R20-20261009","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1002\/pmic.200900447","article-title":"Proteomic analysis of synaptosomal protein expression reveals that cerebral ischemia alters lysosomal Psap processing.","volume":"10","author":"Costain","year":"2010","journal-title":"Proteomics"},{"key":"R21-20261009","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1089\/089771503767869980","article-title":"Regulation of gene expression in response to brain injury: enhanced expression and alternative splicing of rat prosaposin (SGP-1) mRNA in injured brain.","volume":"20","author":"Hiraiwa","year":"2003","journal-title":"J Neurotrauma"},{"key":"R22-20261009","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1006\/bbrc.1994.2558","article-title":"Protection by prosaposin against ischemia-induced learning disability and neuronal loss.","volume":"204","author":"Sano","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"R23-20261009","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/glia.23480","article-title":"Glio\u2010and neuro\u2010protection by prosaposin is mediated by orphan G\u2010protein coupled receptors GPR37L1 and GPR37.","volume":"66","author":"Liu","year":"2018","journal-title":"Glia"},{"key":"R24-20261009","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41589-021-00748-z","article-title":"Orphan receptor GPR37L1 remains unliganded.","volume":"17","author":"Ngo","year":"2021","journal-title":"Nat Chem Biol"},{"key":"R25-20261009","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/1087057113475480","article-title":"Screening \u03b2-arrestin recruitment for the identification of natural ligands for orphan G-protein\u2013coupled receptors.","volume":"18","author":"Southern","year":"2013","journal-title":"J Biomol Screen"},{"key":"R26-20261009","doi-asserted-by":"crossref","first-page":"19995","DOI":"10.1038\/s41598-020-76384-9","article-title":"The N-terminus of GPR37L1 is proteolytically processed by matrix metalloproteases.","volume":"10","author":"Coleman","year":"2020","journal-title":"Sci Rep"},{"key":"R27-20261009","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.nbd.2017.07.006","article-title":"GPR37L1 modulates seizure susceptibility: evidence from mouse studies and analyses of a human GPR37L1 variant.","volume":"106","author":"Giddens","year":"2017","journal-title":"Neurobiol Dis"},{"key":"R28-20261009","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/nar\/28.1.10","article-title":"Database resources of the national center for biotechnology information.","volume":"28","author":"Wheeler","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"R29-20261009","doi-asserted-by":"crossref","first-page":"791081","DOI":"10.3389\/fimmu.2021.791081","article-title":"The chicken embryo model: a novel and relevant model for immune-based studies.","volume":"12","author":"Garcia","year":"2021","journal-title":"Front Immunol"},{"key":"R30-20261009","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nrc3535","article-title":"The hen as a model of ovarian cancer.","volume":"13","author":"Johnson","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"R31-20261009","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1038\/s41598-017-04572-1","article-title":"Non-invasive imaging of engineered human tumors in the living chicken embryo.","volume":"7","author":"Jefferies","year":"2017","journal-title":"Sci Rep"},{"key":"R32-20261009","doi-asserted-by":"crossref","first-page":"15.5.1","DOI":"10.1002\/0471142905.hg1505s40","article-title":"Use of chicken models for the analysis of human disease.","volume":"40","author":"Dodgson","year":"2004","journal-title":"Curr Protocols Human Genetics"},{"key":"R33-20261009","first-page":"28","article-title":"Package \u201csurvival.\u201d.","volume":"128","author":"Therneau","year":"2015","journal-title":"R Top Doc"},{"key":"R35-20261009","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1126\/science.aao4750","article-title":"Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq.","volume":"360","author":"Filbin","year":"2018","journal-title":"Science"},{"key":"R36-20261009","doi-asserted-by":"crossref","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","article-title":"TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment.","volume":"51","author":"Han","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"R37-20261009","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells.","volume":"41","author":"Yang","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"R38-20261009","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy.","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R39-20261009","doi-asserted-by":"crossref","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data.","volume":"22","author":"Maeser","year":"2021","journal-title":"Brief Bioinform"},{"key":"R42-20261009","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-021-00496-y","article-title":"Anti-angiogenic agents \u2013 overcoming tumour endothelial cell anergy and improving immunotherapy outcomes.","volume":"18","author":"Huinen","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"R43-20261009","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41577-019-0257-x","article-title":"B cells, plasma cells and antibody repertoires in the tumour microenvironment.","volume":"20","author":"Sharonov","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"R44-20261009","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1158\/0008-5472.CAN-15-1737","article-title":"A breakthrough: macrophage-directed cancer immunotherapy.","volume":"76","author":"Mills","year":"2016","journal-title":"Cancer Res"},{"key":"R45-20261009","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy.","volume":"124","author":"Raskov","year":"2021","journal-title":"Br J Cancer"},{"key":"R46-20261009","first-page":"1","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression.","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol"},{"key":"R47-20261009","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT.","volume":"2","author":"Chen","year":"2018","journal-title":"Cancer Syst Biol"},{"key":"R48-20261009","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells.","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"R49-20261009","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape.","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol"},{"key":"R50-20261009","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","article-title":"distinct immune cell populations define response to Anti-PD-1 monotherapy and anti-PD-1\/Anti-CTLA-4 combined therapy.","volume":"35","author":"Gide","year":"2019","journal-title":"Cancer Cell"},{"key":"R51-20261009","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.","volume":"350","author":"Van Allen","year":"2015","journal-title":"Science"},{"key":"R52-20261009","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41591-019-0349-y","article-title":"Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma.","volume":"25","author":"Zhao","year":"2019","journal-title":"Nat Med"},{"key":"R53-20261009","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers.","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"key":"R54-20261009","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3390\/genes13101680","article-title":"Characterization of CRH-Binding Protein (CRHBP) in chickens: molecular cloning, tissue distribution and investigation of its role as a negative feedback regulator within the hypothalamus\u2013pituitary\u2013adrenal axis.","volume":"13","author":"Wan","year":"2022","journal-title":"Genes"},{"key":"R55-20261009","doi-asserted-by":"crossref","first-page":"104500","DOI":"10.1016\/j.psj.2024.104500","article-title":"Characterization of the C5H11ORF96 gene in chickens: cloning, tissue distribution and investigation of its potential function in stress response regulation.","volume":"104","author":"Wan","year":"2025","journal-title":"Poult Sci"},{"key":"R56-20261009","doi-asserted-by":"crossref","first-page":"917712","DOI":"10.3389\/fphys.2022.917712","article-title":"Characterization of the chicken melanocortin 5 receptor and its potential role in regulating hepatic glucolipid metabolism.","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Physiol"},{"key":"R57-20261009","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3390\/ani14071034","article-title":"SSTR2 mediates the inhibitory effect of SST\/CST on lipolysis in chicken adipose tissue.","volume":"14","author":"Zhang","year":"2024","journal-title":"Animals"},{"key":"R58-20261009","doi-asserted-by":"crossref","first-page":"104097","DOI":"10.1016\/j.psj.2024.104097","article-title":"Genome-wide mapping of the binding sites of myocyte enhancer factor 2A in chicken primary myoblasts.","volume":"103","author":"Wang","year":"2024","journal-title":"Poult Sci"},{"key":"R59-20261009","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1038\/s41598-021-84140-w","article-title":"Transcriptomic analysis of granulosa cell populations proximal and distal to the germinal disc of chicken preovulatory follicles.","volume":"11","author":"Zhu","year":"2021","journal-title":"Sci Rep"},{"key":"R60-20261009","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1038\/s41598-019-41132-1","article-title":"Transcriptomic diversification of granulosa cells during follicular development in chicken.","volume":"9","author":"Zhu","year":"2019","journal-title":"Sci Rep"},{"key":"R61-20261009","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3390\/ani14071034","article-title":"SSTR2 Mediates the Inhibitory Effect of SST\/CST on lipolysis in chicken adipose tissue.","volume":"14","author":"Zhang","year":"2024","journal-title":"Animals (Basel)"},{"key":"R63-20261009","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41419-024-07240-1","article-title":"GPR37-enhanced ubiquitination of ATP1A1 inhibits tumor progression and radiation resistance in esophageal squamous cell carcinoma.","volume":"15","author":"Hu","year":"2024","journal-title":"Cell Death Dis"},{"key":"R64-20261009","doi-asserted-by":"crossref","first-page":"024","DOI":"10.1515\/med-2021-0011","article-title":"GPR37 promotes the malignancy of lung adenocarcinoma via TGF-\u03b2\/Smad pathway.","volume":"16","author":"Wang","year":"2020","journal-title":"Open Med"},{"key":"R65-20261009","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.expneurol.2018.11.004","article-title":"Genetic ablation of GPR37L1 delays tumor occurrence in Ptch1(\u00b1) mouse models of medulloblastoma.","volume":"312","author":"Di Pietro","year":"2019","journal-title":"Exp Neurol"},{"key":"R66-20261009","doi-asserted-by":"crossref","first-page":"960317","DOI":"10.3389\/fonc.2022.960317","article-title":"Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action.","volume":"12","author":"Tilsed","year":"2022","journal-title":"Front Oncol"},{"key":"R67-20261009","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00262-021-03013-3","article-title":"Chemotherapy: a double-edged sword in cancer treatment.","volume":"71","author":"Behranvand","year":"2022","journal-title":"Cancer Immunol Immun"},{"key":"R68-20261009","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ctrv.2016.01.003","article-title":"Cisplatin in the modern era: the backbone of first-line chemotherapy for non-small cell lung cancer.","volume":"44","author":"Fennell","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"R69-20261009","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3390\/cancers13030400","article-title":"Advances in nanocarriers for effective delivery of docetaxel in the treatment of lung cancer: an overview.","volume":"13","author":"Razak","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R70-20261009","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1111\/1759-7714.14131","article-title":"Efficacy and safety of apatinib alone or apatinib plus paclitaxel\/docetaxel versus paclitaxel\/docetaxel in the treatment of advanced non\u2010small cell lung cancer: a meta\u2010analysis.","volume":"12","author":"Li","year":"2021","journal-title":"Thorac Cancer"},{"key":"R71-20261009","doi-asserted-by":"crossref","first-page":"1157306","DOI":"10.3389\/fphar.2023.1157306","article-title":"Chemotherapeutic properties and side-effects associated with the clinical practice of terpene alkaloids: paclitaxel, docetaxel, and cabazitaxel.","volume":"14","author":"Sousa-Pimenta","year":"2023","journal-title":"Front Pharmacol"},{"key":"R72-20261009","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S1470-2045(23)00016-5","article-title":"Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.","volume":"24","author":"Pignata","year":"2023","journal-title":"Lancet Oncol"},{"key":"R73-20261009","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1470-2045(23)00051-7","article-title":"Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.","volume":"24","author":"Tolaney","year":"2023","journal-title":"Lancet Oncol"},{"key":"R74-20261009","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2174\/1389557520999201214234421","article-title":"Resistance to intervention: paclitaxel in breast cancer.","volume":"21","author":"Dan","year":"2021","journal-title":"Mini Rev Med Chem"},{"key":"R75-20261009","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","article-title":"Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"R76-20261009","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1158\/2326-6066.CIR-21-1017","article-title":"Coming of age: human genomics and the cancer\u2013immune set point.","volume":"10","author":"Hammer","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"R77-20261009","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1016\/S1470-2045(16)30406-5","article-title":"Predictive biomarkers for checkpoint inhibitor-based immunotherapy.","volume":"17","author":"Gibney","year":"2016","journal-title":"Lancet Oncol"},{"key":"R78-20261009","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40364-022-00378-0","article-title":"The role of biomarkers in personalized immunotherapy.","volume":"10","author":"Sankar","year":"2022","journal-title":"Biomark Res"},{"key":"R79-20261009","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy.","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"R80-20261009","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"R81-20261009","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fimmu.2019.00333","article-title":"Chemokines modulate immune surveillance in tumorigenesis, metastasis, and response to immunotherapy.","volume":"10","author":"Vilgelm","year":"2019","journal-title":"Front Immunol"},{"key":"R82-20261009","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1096\/fj.08-121210","article-title":"Induction of macroautophagy by overexpression of the Parkinson\u2019s disease-associated GPR37 receptor.","volume":"23","author":"Marazziti","year":"2009","journal-title":"FASEB J"},{"key":"R83-20261009","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrd.2017.178","article-title":"Trends in GPCR drug discovery: new agents, targets and indications.","volume":"16","author":"Hauser","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"R84-20261009","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1074\/jbc.M113.510883","article-title":"GPR37 protein trafficking to the plasma membrane regulated by prosaposin and GM1 gangliosides promotes cell viability.","volume":"289","author":"Lundius","year":"2014","journal-title":"J Biol Chem"},{"key":"R86-20261009","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3390\/biomedicines10051006","article-title":"Osteocalcin alleviates lipopolysaccharide-induced acute inflammation via activation of GPR37 in macrophages.","volume":"10","author":"Qian","year":"2022","journal-title":"Biomedicines"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047813","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:08:20Z","timestamp":1791569300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":81,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047813","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"2025-08-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}